16:53:56 EST Fri 06 Feb 2026
Enter Symbol
or Name
USA
CA



Login ID:
Password:
Save

V:NGEN - Nervgen Pharma Corp. - https://www.nervgen.com/
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
NGEN - V  0.15.35·5.400.15.35+0.091.7124.56523725.28  5.49  5.258.49  2.5715:59:54Jan 2015 min RT 2¢
TSX-V - V0.15.35·5.400.15.35+0.091.7101.05302325.28  5.49  5.258.49  2.5715:59:5415 min
NEO ATS - U 5.35+0.091.73.116315.35  5.45  5.3515:59:5015 min
Alpha - A 5.39+0.132.50.9555.27  5.43  5.2715:57:2015 min
Omega - O 5.35+0.091.72.71465.44  5.44  5.3510:59:2015 min
CSE ATS - P 5.36+0.101.91.1665.36  5.36  5.3610:48:1315 min
CXC - X 5.40+0.142.76.434195.28  5.42  5.2713:44:4315 min
CX2 - H 5.39+0.132.50.8485.35  5.40  5.3515:57:2015 min
CXD - D 5.34+0.081.50.74135.28  5.34  5.2810:48:1215 min
MatchNOW - M 5.262.21130    Sep 04-2015 min
Lynx - Y 5.35+0.091.75.629225.27  5.49  5.2515:59:4915 min

Recent Trades - Last 10 of 372
Time ETExPriceChangeVolumeBuyerSellerMarkers
15:59:54V5.350.0910084 ITG841 AnonymousK
15:59:54V5.350.0910084 ITG841 AnonymousK
15:59:53V5.350.0910084 ITG841 AnonymousK
15:59:50U5.350.091002 RBC79 CIBCK
15:59:49Y5.350.0910079 CIBC1 AnonymousK
15:59:40V5.370.1110079 CIBC1 AnonymousK
15:58:07Y5.350.0910079 CIBC1 AnonymousK
15:57:20A5.390.132007 TD Sec79 CIBCK
15:57:20H5.390.131007 TD Sec79 CIBCK
15:57:20V5.390.131007 TD Sec1 AnonymousK

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolPriceTypeHeadline
2026-01-20 07:00C:NGEN7.31News ReleaseNervGen Pharma to Ring the Nasdaq Closing Bell on January 22, 2026, Celebrating Its Recent Nasdaq Listing
2026-01-08 12:16C:NGEN7.82News ReleaseNervgen begins trading on Nasdaq
2025-12-17 23:55C:NGEN6.00News ReleaseNervgen files Form F-10 registration statement with SEC
2025-12-15 21:39C:NGEN5.80MiscellaneousNervgen Pharma warrants repriced
2025-12-12 20:13C:NGEN6.00News ReleaseNervgen Pharma plans to amend warrants
2025-11-27 18:08C:NGEN5.31Private PlacementNervgen Pharma 4,785,674-share private placement
2025-11-24 07:25C:NGEN4.00SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2025-11-24 07:25C:NGEN4.00SEDAR Interim MD & ASEDAR Interim MD & A
2025-11-24 07:06C:NGEN4.00News ReleaseNervGen Pharma Reports Third Quarter Financial Results and Provides Business Updates
2025-11-24 07:02C:NGEN4.00News ReleaseNervGen Pharma Announces Expanded CONNECT SCI Study Data Demonstrating Unprecedented Durable Improvement in Function, Independence, and Quality of Life in Chronic Spinal Cord Injury
2025-11-19 20:03C:NGEN3.65News ReleaseNervgen Pharma closes $10.04-million (U.S.) financing
2025-11-18 16:43C:NGEN3.25News ReleaseNervGen Pharma Announces US$10 Million Non-Brokered Private Placement to Support Anticipated Nasdaq Listing and Advance NVG-291 Development
2025-08-26 07:31C:NGEN3.66News ReleaseNervGen Pharma Reports Second Quarter Financial Results and Provides Letter to Shareholders
2025-08-26 07:16C:NGEN3.66SEDAR Interim MD & ASEDAR Interim MD & A
2025-08-26 07:09C:NGEN3.66SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2025-08-21 17:24C:NGEN3.48News ReleaseNervgen's NVG-291-R studies suggest hearing recovery
2025-07-18 19:49C:NGEN3.75Prospectus ApprovedNervgen Pharma prospectus offering of 385,200 shares
2025-07-17 17:02C:NGEN3.80News ReleaseNervgen president, CEO, director Kelly resigns
2025-07-08 03:47C:NGEN3.50News ReleaseNervgen sells 385,200 shares under ATM program in Q2
2025-07-03 19:55C:NGEN3.49News ReleaseNervgen Pharma director Ives resigns